TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19575742

Group type: EXPERIMENTAL
Intervention: Modified patient-maintained target-controlled infusion (TCI) of propofol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patient-controlled Entonox inhalation
Number of subjects: 100
Study: 20614697

Group type: EXPERIMENTAL
Intervention: Better control (Hb A1c < 9%)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Poor control (Hb A1c > 9%)
Number of subjects: 126
Study: 16765849

Group type: EXPERIMENTAL
Intervention: Group music with movement intervention (twice a week for 4 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care without intervention
Number of subjects: 36
Study: 15301650

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) in group therapy format
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) in individual face-to-face therapy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) through brief individual telephone consultations
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study: 11142580

Group type: EXPERIMENTAL
Intervention: 0.2% glyceryl trinitrate ointment (PMF 303)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Common preparation of glyceryl trinitrate ointment
Number of subjects: 12
Study: 9487449

Group type: EXPERIMENTAL
Intervention: Beta-sitosterol
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (talcum powder)
Number of subjects: 37
Study: 8404405

Group type: EXPERIMENTAL
Intervention: 5-ASA colonic foam
Number of subjects: 233

Group type: COMPARATOR
Intervention: 5-ASA enema
Number of subjects: 233
Study: 3526866

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional pertussis vaccine
Number of subjects: 80
Study: 29754669

Group type: EXPERIMENTAL
Intervention: FFR-guided PCI strategy
Number of subjects: 1700

Group type: COMPARATOR
Intervention: IVUS-guided PCI strategy
Number of subjects: 1700
Study: 27296723

Group type: EXPERIMENTAL
Intervention: Play & Grow intervention (weekly one-hour activity sessions for 10 weeks)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Connectedness to nature (part of the Play & Grow intervention)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Nature Relatedness Scale (NRS)
Number of subjects: 240
Study: 24561645

Group type: EXPERIMENTAL
Intervention: Video-based intervention teaching SNAPPI
Number of subjects: 0
Study: 23880545

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 0
Study: 20100629

Group type: EXPERIMENTAL
Intervention: Online assessment tool
Number of subjects: 50

Group type: COMPARATOR
Intervention: Practical assessment tool (OSCE style)
Number of subjects: 50
Study: 18324427

Group type: EXPERIMENTAL
Intervention: Caspofungin therapy for invasive candidiasis (IC)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Caspofungin therapy for invasive aspergillosis (IA)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Caspofungin therapy as empirical therapy (ET)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Caspofungin therapy
Number of subjects: 159
Study: 16193475

Group type: EXPERIMENTAL
Intervention: School-based health centers (SBHCs) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control schools (no SBHCs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (intervention and control)
Number of subjects: 0
Study: 12382303

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 10790574

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 7755939

Group type: EXPERIMENTAL
Intervention: Felodipine (5 to 20 mg; n = 13)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ramipril (2.5 to 10 mg; n = 15)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (normotensive men)
Number of subjects: 28
Study: 2274600

Group type: EXPERIMENTAL
Intervention: Propranolol (20-80 mg bid)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Clonidine (0.1-0.3 mg bid)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Propranolol (20-40 mg bid)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 7027073

Group type: EXPERIMENTAL
Intervention: Bobath
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vojta
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 30924254

Group type: EXPERIMENTAL
Intervention: 3-in-1 night facial serum (NFS) containing melatonin, bakuchiol, and ascorbyl tetraisopalmitate, applied once daily for 12 weeks
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 3-in-1 night facial serum (NFS)
Number of subjects: 103
Study: 30954276

Group type: COMPARATOR
Intervention: Incremental Cycle Test (ICT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ISWT and 6MWT
Number of subjects: 40
Study: 29162117

Group type: EXPERIMENTAL
Intervention: Community-based intervention including advocacy meetings, training community representatives for peer education, and integrating awareness creation with community health extension program.
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Active comparator group without husband involvement in the intervention.
Number of subjects: 1269
Study: 26158441

Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound-guided transbronchial needle aspiration with rapid on-site evaluation (ROSE)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Endobronchial ultrasound-guided transbronchial needle aspiration without rapid on-site evaluation (EBUS)
Number of subjects: 126
Study: 24501946

Group type: EXPERIMENTAL
Intervention: Itopride (IG) 50 mg 3 times a day (tid)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Domperidone (DP) 10 mg tid
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Itopride (IG)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Domperidone (DP)
Number of subjects: 90
Study: 21626121

Group type: EXPERIMENTAL
Intervention: Betahistine dihydrochloride 288-480 mg/day
Number of subjects: 11
Study: 17530429

Group type: EXPERIMENTAL
Intervention: CMF (cyclophosphamide, methotrexate, 5‐fluorouracil)
Number of subjects: 281
Study: 17123186

Group type: EXPERIMENTAL
Intervention: Active Cranial Electrotherapy Stimulation (CES)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham Cranial Electrotherapy Stimulation (CES)
Number of subjects: 38
Study: 12642755

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 49
Study: 10842890

Group type: COMPARATOR
Intervention: Randomized clinical trial design measuring drug activity on acute parameters.
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Measurement of efficacy in clinical practice.
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Observational studies as an alternative to randomized trials.
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Parameters considered fundamental by the patient (chronic pain, disability, radiographic alterations).
Number of subjects: 102
Study: 9314427

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 to 10 mg BID) on high-salt diet
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 to 10 mg BID) on low-salt diet
Number of subjects: 21
Study: 8363080

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham product
Number of subjects: 56
Study: 3524465

Group type: EXPERIMENTAL
Intervention: Immunochemotherapy (L-I-C)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Post-operative chemotherapy (L-I-C)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Long-term continuous chemotherapy (L-C-C)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Long-term continuous chemotherapy (L-C-C) with CQ+CPA+ADM+5-FU
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Post-operative radiation therapy
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Immunotherapy combined with radiation therapy
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Bronchial arterial infusion (BAI)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Short-term chemotherapy (S-C)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Long-term intermittent chemotherapy (L-I-C)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Chemotherapy (control group)
Number of subjects: 234
Study: 29792037

Group type: EXPERIMENTAL
Intervention: Povidone‐iodine pleurodesis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bleomycin pleurodesis
Number of subjects: 60
Study: 27734748

Group type: EXPERIMENTAL
Intervention: Cetuximab with radiotherapy (ERT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cisplatin with radiotherapy (CRT)
Number of subjects: 20
Study: 23999209

Group type: EXPERIMENTAL
Intervention: Custom cutting blocks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional TKA instrumentation
Number of subjects: 80
Study: 22059447

Group type: EXPERIMENTAL
Intervention: Presence of category labels during similarity judgments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Absence of category labels during similarity judgments
Number of subjects: 0
Study: 20675691

Group type: EXPERIMENTAL
Intervention: Baseline serum fibrosis markers (HA, YKL-40, TIMP-1)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Baseline HA and platelet counts
Number of subjects: 462
Study: 18774627

Group type: EXPERIMENTAL
Intervention: Hospital meals
Number of subjects: 60
Study: 15761945

Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers with fine particle doses (FPDs) of 100 microg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers with fine particle doses (FPDs) of 120 microg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers with fine particle doses (FPDs) of 160 microg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers
Number of subjects: 12
Study: 12649515

Group type: EXPERIMENTAL
Intervention: Triflusal (600 mg/d)
Number of subjects: 2113

Group type: COMPARATOR
Intervention: Aspirin (325 mg/d)
Number of subjects: 2113

Group type: EXPERIMENTAL
Intervention: Triflusal
Number of subjects: 2113

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2113
Study: 10357343

Group type: COMPARATOR
Intervention: Granisetron 3 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg plus dexamethasone 8 mg
Number of subjects: 120
Study: 8730935

Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 0

Group type: COMPARATOR
Intervention: TCAs
Number of subjects: 0
Study: 2802477

Group type: EXPERIMENTAL
Intervention: Endoscopic dilatation and antireflux medication
Number of subjects: 195

Group type: COMPARATOR
Intervention: Antireflux surgery
Number of subjects: 195
Study: 990784

Group type: EXPERIMENTAL
Intervention: Naloxone 40 mug administered intravenously one minute after birth
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (epidural block)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Untreated neonates of mothers who had pethidine
Number of subjects: 44
Study: 31185078

Group type: EXPERIMENTAL
Intervention: Scabies prevalence in the population examined
Number of subjects: 1879
Study: 29163985

Group type: EXPERIMENTAL
Intervention: Inhaled loxapine 5 or 10 mg
Number of subjects: 658

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 658
Study: 26288391

Group type: EXPERIMENTAL
Intervention: Trail Making Test A and B (TM A and B) at enrollment and at 12 and 24 months
Number of subjects: 2128

Group type: EXPERIMENTAL
Intervention: Changes in TM B times
Number of subjects: 2128

Group type: EXPERIMENTAL
Intervention: Changes in TM scores
Number of subjects: 2128

Group type: EXPERIMENTAL
Intervention: Lung function, PaO2, smoking status
Number of subjects: 2128
Study: 23456209

Group type: EXPERIMENTAL
Intervention: Sedentary time
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Breaks in sedentary time
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Total physical activity
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: MVPA
Number of subjects: 878
Study: 22187590

Group type: EXPERIMENTAL
Intervention: Counseling by community volunteers in the intervention group
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 179
Study: 19929234

Group type: EXPERIMENTAL
Intervention: Telehealth group using the Health Buddy system for an additional 180 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving no further telehealth or home health services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telehealth group
Number of subjects: 0
Study: 22369559

Group type: EXPERIMENTAL
Intervention: Glass-ionomer cements (GICs) and resin-modified glass-ionomer cements (RMGICs) incorporated with 2% chlorhexidine (CHX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group: Conventional glass-ionomer cements (GIC) and resin-modified glass-ionomer cements (RMGIC) without chlorhexidine
Number of subjects: 0
Study: 16519083

Group type: EXPERIMENTAL
Intervention: Early postpartum mother-baby skin-to-skin contact
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Early initiation of breastfeeding
Number of subjects: 92

Group type: COMPARATOR
Intervention: Mode of delivery (vaginal or caesarian)
Number of subjects: 92
Study: 12006271

Group type: EXPERIMENTAL
Intervention: n‐BCA/Tantalum Powder/Ethiodized Oil mixture
Number of subjects: 104

Group type: COMPARATOR
Intervention: Trufill polyvinyl alcohol (PVA)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: n‐BCA
Number of subjects: 104

Group type: COMPARATOR
Intervention: PVA
Number of subjects: 104
Study: 9834807

Group type: EXPERIMENTAL
Intervention: Bevel parallel to the longitudinal axis of the dural cylinder
Number of subjects: 212

Group type: COMPARATOR
Intervention: Bevel transverse to the longitudinal axis of the dural cylinder
Number of subjects: 212
Study: 8083144

Group type: EXPERIMENTAL
Intervention: Children with ADHD
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 23
Study: 2916917

Group type: EXPERIMENTAL
Intervention: Viscoelastic insoles
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo foam insoles
Number of subjects: 139
Study: 939844

Group type: EXPERIMENTAL
Intervention: Perceived own control over noise condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: No control over noise condition
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Constant rate of exposure to noise
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Increasing rate of exposure to noise
Number of subjects: 40
Study: 31991617

Group type: EXPERIMENTAL
Intervention: Better education
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Shift work
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Nurses in management positions
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Scale of well-being
Number of subjects: 523
Study: 30093595

Group type: EXPERIMENTAL
Intervention: Notification of patients' deaths and a safe prescribing injunction from the county's medical examiner
Number of subjects: 861

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 861
Study: 29474712

Group type: EXPERIMENTAL
Intervention: Average on-treatment SBP ≤130 mmHg
Number of subjects: 8778

Group type: COMPARATOR
Intervention: Average on-treatment SBP between 131 and 141 mmHg
Number of subjects: 8778

Group type: COMPARATOR
Intervention: Average on-treatment SBP ≥142 mmHg
Number of subjects: 8778
Study: 24229565

Group type: EXPERIMENTAL
Intervention: Entacapone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23328286

Group type: EXPERIMENTAL
Intervention: 30 ml/d lactulose
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 60 ml/d lactulose
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 90 ml/d lactulose
Number of subjects: 112
Study: 20131262

Group type: EXPERIMENTAL
Intervention: LY2439821 (0.2 mg/kg)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: LY2439821 (2.0 mg/kg)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: All LY2439821 combined
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: LY2439821 (0.2, 0.6, or 2.0 mg/kg)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: LY2439821
Number of subjects: 97
Study: 18467621

Group type: EXPERIMENTAL
Intervention: Digital photoplethysmography (D‐PPG) test in patients with high PAP
Number of subjects: 90

Group type: COMPARATOR
Intervention: Digital photoplethysmography (D‐PPG) test in patients without high PAP
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Correlation between venous refilling time (RT) and D‐PPG results in patients with high PAP
Number of subjects: 90

Group type: COMPARATOR
Intervention: Correlation between venous refilling time (RT) and D‐PPG results in patients without high PAP
Number of subjects: 90
Study: 15808630

Group type: EXPERIMENTAL
Intervention: Celsior (CEL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Histidine Tryptophan Ketoglutarate (HTK)
Number of subjects: 40
Study: 12027796

Group type: EXPERIMENTAL
Intervention: Radial artery grafts (RA), n=154 patients
Number of subjects: 289

Group type: COMPARATOR
Intervention: Saphenous vein grafts (SVG), n=135 patients
Number of subjects: 289
Study: 12198775

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8746882

Group type: EXPERIMENTAL
Intervention: 2 mg estradiol-valerat (E2V) and 10 mg dydrogesterone for 10 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: No hormonal treatment
Number of subjects: 23
Study: 2143712

Group type: EXPERIMENTAL
Intervention: d‐fenfluramine (30 mg daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: placebo plus low‐calorie diet (1500‐1200 kcal daily)
Number of subjects: 42
Study: 7391826

Group type: EXPERIMENTAL
Intervention: Condition designed to elicit spontaneous fantasy behavior
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control condition designed to be incompatible with fantasy
Number of subjects: 57
Study: 31983177

Group type: EXPERIMENTAL
Intervention: Metronomic chemotherapy
Number of subjects: 81

Group type: COMPARATOR
Intervention: Palliative hydroxyurea
Number of subjects: 81
Study: 31076620

Group type: EXPERIMENTAL
Intervention: CNN-based system for predicting patient sex from FDG PET-CT images
Number of subjects: 6462

Group type: EXPERIMENTAL
Intervention: Image-masking simulation
Number of subjects: 6462

Group type: EXPERIMENTAL
Intervention: CNN-based system
Number of subjects: 6462
Study: 27742394

Group type: EXPERIMENTAL
Intervention: Whole-egg powder
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo (rice powder)
Number of subjects: 319
Study: 26170041

Group type: EXPERIMENTAL
Intervention: Vitamin D and leucine-enriched whey protein nutritional supplement
Number of subjects: 380

Group type: COMPARATOR
Intervention: Iso-caloric control product
Number of subjects: 380
Study: 24021479

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance tests (OGTTs) and waist measurement
Number of subjects: 0
Study: 21306829

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 19693675

Group type: EXPERIMENTAL
Intervention: Postcon-60s
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Postcon-30s
Number of subjects: 75

Group type: COMPARATOR
Intervention: Routine
Number of subjects: 75
Study: 17578485

Group type: EXPERIMENTAL
Intervention: Pramipexole 0.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of Pramipexole 0.5 mg and Domperidone 40 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Domperidone 40 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 14969424

Group type: EXPERIMENTAL
Intervention: Passive perception of deviant signal (stimuli evoking mismatch negativity)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive perception of stimuli not evoking mismatch negativity
Number of subjects: 0
Study: 11037740

Group type: EXPERIMENTAL
Intervention: 5-isosorbide-mononitrate (5-ISMN) 30 mg administered orally three times daily for 4 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 9
Study: 9265038

Group type: EXPERIMENTAL
Intervention: TX 1341 (3 chewable lactate and citrate of magnesium tablets, each containing 120 mg of magnesium-element)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Reference magnesium (MAG2, 3 drinkable ampoules of pidolate of magnesium, each containing 122 mg of magnesium-element)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: TX 1341
Number of subjects: 179

Group type: COMPARATOR
Intervention: Reference magnesium
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Both TX 1341 and Reference magnesium
Number of subjects: 179
Study: 1473444

Group type: EXPERIMENTAL
Intervention: 0.01% carbachol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Balanced salt solution (BSS)
Number of subjects: 60
Study: 4034460

Group type: EXPERIMENTAL
Intervention: Fecatwin
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Haemoccult
Number of subjects: 780
Study: 31852916

Group type: EXPERIMENTAL
Intervention: Presence module
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Affect module
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Perspective module
Number of subjects: 298
Study: 29701167

Group type: EXPERIMENTAL
Intervention: Maze procedure (AF ablation device)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Control (routine cardiac surgery without maze procedure)
Number of subjects: 352
Study: 27326985

Group type: EXPERIMENTAL
Intervention: Cetirizine, fexofenadine, bilastine, desloratadine, or ebastine (daily oral dose for 8 weeks)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Higher dose of antihistamine after 4 weeks for non-responders
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no antihistamine treatment)
Number of subjects: 150
Study: 24736647

Group type: EXPERIMENTAL
Intervention: 1.4 g of EPA+DHA daily oil capsule supplements (n=24)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Identical appearing soybean oil (n=21)
Number of subjects: 45
Study: 22568611

Group type: EXPERIMENTAL
Intervention: High-frequency TENS (100 Hz frequency, 75 µs pulse for 60 min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40